ICML 2019 | Time-limited therapy in CLL

Barbara Eichhorst

Barbara Eichhorst, MD, University Hospital of Cologne, Cologne, Germany, discusses the emergence of time-limited therapy in chronic lymphocytic leukemia (CLL). This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video